DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Show other versions (1)

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...

書目詳細資料
Main Authors:	Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H
格式:	Journal article
語言:	English
出版:	2010

相似書籍

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
由: Wordsworth, S, et al.
出版: (2006)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
由: Wordsworth, S, et al.
出版: (2010)

Evaluation of Clinical Diagnostic Potential of Next Generation Sequencing using Hypertrophic Cardiomyopathy as a Model
由: Taylor, J, et al.
出版: (2010)

A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner
由: Thistleton, J, et al.
出版: (2007)

Expansion of a diagnostic service for hypertrophic cardiomyopathy using next generation sequencing
由: Reid, S, et al.
出版: (2011)

Linked genetic modifiers in hypertrophic cardiomyopathy
由: Ektisham, J, et al.
出版: (2004)

Oxford Molecular Genetics Laboratory Cardiomyopathy Service
由: Thistleton, J, et al.
出版: (2006)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
由: Blair, E, et al.
出版: (2003)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
由: Ashrafian, H, et al.
出版: (2003)

Identification of a novel mitochondrial DNA mutation in the ND1 gene in 2 patients with hypertrophic cardiomyopathy with restrictive physiology
由: Khogali, S, et al.
出版: (2001)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
由: Carballo, S, et al.
出版: (2003)

Sudden death in hypertrophic cardiomyopathy.
由: Watkins, H
出版: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
由: Ashrafian, H, et al.
出版: (2001)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
由: Carballo, S, et al.
出版: (2005)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
由: Carballo, S, et al.
出版: (2005)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
由: Hudsmith, L, et al.
出版: (2006)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
由: Blair, E, et al.
出版: (2000)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
由: Waring, A, et al.
出版: (2020)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
由: Ashrafian, H, et al.
出版: (2005)

Eliciting expert opinion for economic models: an applied example.
由: Leal, J, et al.
出版: (2007)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
由: Carballo, S, et al.
出版: (2005)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
由: Blair, E, et al.
出版: (2001)

The genetics of hypertrophic cardiomyopathy: Teare redux.
由: Watkins, H, et al.
出版: (2008)

Experience in genetic testing of hypertrophic cardiomyopathy using nanopore DNA sequencing
由: R. R. Salakhov, et al.
出版: (2021-11-01)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
由: Carballo, S, et al.
出版: (2004)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
由: Watkins, H
出版: (2003)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
由: Redwood, C, et al.
出版: (2003)

Identification of a novel mitochondrial NADH dehydrogenase I (MTND1) gene mutation in two patients with hypertrophic cardiomyopathy
由: Khogali, S, et al.
出版: (2001)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
由: Watkins, H
出版: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
由: Watkins, H
出版: (2013)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
由: Manning Warren J, et al.
出版: (2009-01-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
由: Watkins, H, et al.
出版: (2005)

Hypertrophic Cardiomyopathy
由: Asra K. Butt, et al.
出版: (2023-03-01)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
由: Ashrafian, H, et al.
出版: (2011)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
由: Suttie, J, et al.
出版: (2011)

Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.
由: Christian M Hagen, et al.
出版: (2015-01-01)

Hypertrophic cardiomyopathy
由: Sarita Gore, et al.
出版: (2022-01-01)

Hypertrophic Cardiomyopathy
由: Polakit Teekakirikul, MD, et al.
出版: (2021-09-01)

Hypertrophic cardiomyopathy
由: Murillo de Oliveira Antunes, et al.
出版: (2020-04-01)

The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy
由: Lidija Mikic, et al.
出版: (2023-07-01)